NDC 24477-020 - DepoDur
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24477-020
- Package NDCs from labels
- 24477-020-04, 24477-020-05
- Manufacturer
- Pacira Pharmaceuticals Inc.
- Effective date
- 2008-01-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DepoDur ® (morphine sulfate extended-release liposome injection) CII Rx Only | Pacira Pharmaceuticals Inc. | 2008-01-10 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24477-020-04 | DepoDur | 1 mL in 1 VIAL, SINGLE-USE | INJECTION, LIPID COMPLEX | 1 | 5 | |
| 24477-020-04 | DepoDur | 5 in 1 CARTON | INJECTION, LIPID COMPLEX | 5 | 5 | |
| 24477-020-05 | DepoDur | 5 in 1 CARTON | INJECTION, LIPID COMPLEX | 5 | 5 | |
| 24477-020-05 | DepoDur | 1.5 mL in 1 VIAL, SINGLE-USE | INJECTION, LIPID COMPLEX | 1.5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| morphine sulfate | ACTIVE INGREDIENT | X3P646A2J0 | DEPODUR (MORPHINE SULFATE) INJECTION, LIPID COMPLEX [PACIRA PHARMACEUTICALS INC.] | 5 | |
| morphine | ACTIVE MOIETY | 76I7G6D29C | DEPODUR (MORPHINE SULFATE) INJECTION, LIPID COMPLEX [PACIRA PHARMACEUTICALS INC.] | 5 | |
| cholesterol | INACTIVE INGREDIENT | 97C5T2UQ7J | DEPODUR (MORPHINE SULFATE) INJECTION, LIPID COMPLEX [PACIRA PHARMACEUTICALS INC.] | 5 | |
| DOPC | INACTIVE INGREDIENT | DEPODUR (MORPHINE SULFATE) INJECTION, LIPID COMPLEX [PACIRA PHARMACEUTICALS INC.] | 5 | ||
| DPPG | INACTIVE INGREDIENT | DEPODUR (MORPHINE SULFATE) INJECTION, LIPID COMPLEX [PACIRA PHARMACEUTICALS INC.] | 5 | ||
| tricapryline | INACTIVE INGREDIENT | DEPODUR (MORPHINE SULFATE) INJECTION, LIPID COMPLEX [PACIRA PHARMACEUTICALS INC.] | 5 | ||
| triolein | INACTIVE INGREDIENT | O05EC62663 | DEPODUR (MORPHINE SULFATE) INJECTION, LIPID COMPLEX [PACIRA PHARMACEUTICALS INC.] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Morphine Sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | b7b86b6d-9a39-494c-bf65-f62e4cdc5807 | 2023-03-02 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate |
| Morphine Sulfate | MORPHINE SULFATE | Winder Laboratories LLC | e9a7319a-bf1f-48db-a71e-6d4e6ead9555 | 2022-02-28 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.